Harvard Surgery of the Thyroid and Parathyroid Gland 2022

Harvard Surgery of the Thyroid and Parathyroid Gland 2022

Include: 8 videos + 3 pdfs, size: 15.72 GB

Target Audience: endocrinologists, surgeons, otolaryngologists

Information:

he Harvard Surgery of the Thyroid and Parathyroid Glands (2022) course provided a comprehensive review of the latest advances in thyroid and parathyroid surgery. It covered:

• Preoperative evaluation and management of thyroid and parathyroid conditions.
• Surgical techniques, including minimally invasive approaches and recurrent laryngeal nerve monitoring.
• Molecular genetic analysis for thyroid carcinoma and oncogene research.
• Thermal ablation options for thyroid nodules and thyroid cancer.
• Postoperative management, including complication prevention and treatment.

This two-day course, offered since 1996, featured panel discussions, tumor boards, and expert-led lectures to enhance learning.

The target audience included:

• Endocrinologists managing thyroid and parathyroid disorders.
• Surgeons specializing in head and neck surgery.
• Otolaryngologists focusing on thyroid and parathyroid procedures.
• Medical trainees seeking advanced education in thyroid and parathyroid surgery.
• Healthcare providers interested in the latest surgical techniques and molecular analysis.

Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

• Agenda.pdf
  November 18.mp4
  November 18.pdf
  November 19.mp4
  November 19.pdf
  Workshop1.mp4
  Workshop2.mp4
  Workshop3.mp4
  Workshop4.mp4
  Workshop5.mp4
  Workshop6.mp4

* Detail:

FRIDAY, NOVEMBER 18 , 2022

• 7:00 – 7:15 AM Welcome/Introduction and Pre-Test Administration Greg Randolph, Keith Lillemoe, Mark Varvares, Carrie Cunningham
  7:15 – 7:45 AM Lecture 1: The Thyroid Nodule in 2022 Gilbert Daniels
  7:45 – 8:10 AM Lecture 2: Molecular Testing for FLUS Douglas Ross
  8:10 – 8:30 AM Lecture 3: RF Ablation of Thyroid Nodules and Cancer Jung Hwan Baek
  8:30 – 8:50 AM Lecture 4: Surgery, Thermal Ablation, or Active Surveillance? Peter Kopp
  8:50 – 9:20 AM Lecture 5: ATA Nodules Guidelines Tour – What the Clinician Needs to Know Lisa Orloff
  9:20 – 10:00 AM Lecture 6: Kocher Lecture-AI and US Franklin Tessler
  10:00 – 10:20 AM Break
  10:20 – 10:40 AM Lecture 7: Low-Risk DTC –Follow Up After Hemithyroidectomy Nikolaos Stathatos
  10:40 – 11:00 AM Lecture 8: Thyroid Care and COVID – Lemonade Study Carrie Cunningham
  11:00 – 11:20 AM Lecture 9: Lessons from PTmC Observation Michael Tuttle
  11:20 – 11:40 AM Lecture 10: ATA Thyroid Cancer Guidelines Tour – What the Clinician Needs to Know Julie Ann Sosa
  11:40 AM – 12:00 PM Lecture 11: ATA Anaplastic Guidelines Tour – What the Clinician Needs to Know Kate Newbold
  12:00 – 12:30 PM PANEL 1: Thyroid Nodules Rx Decisions and Q&A Moderators: Greg Randolph, Nancy Cho Panel: Bryan McIver, Peter Kopp, Julie Ann Sosa
  12:30 – 1:30 PM Lunch Break
  1:30 -1:50 PM Lecture 12: AHNS/ ITOG Advanced Disease Consensus David Shonka
  1:50 – 2:10 PM Lecture 13: Braf Altered ATC Treatment Mark Zafereo
  2:10 – 2:30 PM Lecture 14: Hurthle Cell Carcinoma Management Bryan Haugen
  2:30 – 2:50 PM Lecture 15: Hurtle Cell Carcinoma Genetics Ian Ganly
  2:50 – 3:10 PM Coffee Break
  3:10 – 3:30 PM Lecture 16: RAI 2022 Bryan McIver
  3:30 – 3:50 PM Lecture 17: RAI Rediff Alan Ho
  3:50 – 4:10 PM Lecture 18: Advanced Thyroid Cancer – Treatment Initiation Lori Wirth
  4:10 – 4:30 PM Lecture 19: Avoiding complications in Neck Dissection and Approach to Retropharynx Derrick Lin
  4:30 – 4:50 PM Lecture 20: Neoadjuvant Therapy for Advanced Disease Greg Randolph
  4:50 – 5:10 PM Lecture 21: Surgical Complications from the Endocrine Point of View Megan Haymart
  5:10 – 5:45 PM PANEL 2: Thyroid Cancer Tumor Board and Q&A Moderators: Greg Randolph, Paul Konowitz Panel: Lori Wirth, Alan Ho, Bryan Haugen, Jeremy Richmon, Hien Tierney, Sareh Parangi, Marika Russell
  5:45 – 6:00 PM Adjourn Day 1

SATURDAY, NOVEMBER 19, 2022

• 7:00 – 7:20 AM Lecture 1: Graves, RAI and Breast Cancer: An Update Cari Meinhold Kitahara
  7:20 – 7:40 AM Lecture 2: Surgery for Graves Richard Hodin
  7:40 – 8:00 AM Lecture 3: Graves Opthalamopathy 2022 Suzanne Freitag
  8:00 – 8:40 AM Lecture 4: Cope Lecture-Hypoparathyroidism Anders Bergenfelz
  8:40 – 9:00 AM Lecture 5: Auto Florescence and ICG angiography-State of the Art 2022 Frederic Triponez
  9:00 – 9:30 AM Break
  9:30 -10:00 AM Lecture 6: 2nd HPT Surgery: When and How Much? Peter Angelos
  10:00 – 10:20 AM Lecture 7: HPT Imaging : 4D CT Hillary Kelly
  10:20 – 10:40 AM Lecture 8: Practical office US 2022 Giuseppe Barbesino
  10:40 -11:20 AM Lecture 9: Lessons from Chernobyl and Fukushima Furio Pacini
  11:20 AM -12:30 PM Lunch Break  Faculty Immersion Course Segment: Individualized Case Studies: 2 teaching faculty per room; 20-25 attendees per room & each breakout room will have a different case
  Round 1: 12:30 – 1:15 PM
  Breakout Room #1: Thyroid Cancer Low Risk (Michael Tuttle, Lisa Orloff)
  Breakout Room #2: Primary HPT (Quan Duh, Carrie Cunningham)
  Breakout Room #3: Thyroid Nodules (Peter Kopp, Megan Haymart)
  Breakout Room #4 Thyroid Cancer High Risk (Greg Randolph, Bryan Haugen)
  Breakout Room #5: 2nd HPT (Peter Angelos, Antonia Stephen)
  Breakout Room #6: Molecular Evaluation Dx and Px (Lori Wirth, Bryan McIver)
  1:15 – 1:30 PM Break
  Round 2: 1:30 – 2:15 PM
  Breakout Room #1: Thyroid Cancer Low Risk (Michael Tuttle, Lisa Orloff)
  Breakout Room #2: Primary HPT (Quan Duh, Carrie Cunningham)
  Breakout Room #3: Thyroid Nodules (Peter Kopp, Megan Haymart)
  Breakout Room #4 Thyroid Cancer High Risk (Greg Randolph, Bryan Haugen)
  Breakout Room #5: 2nd HPT (Peter Angelos, Antonia Stephen)
  Breakout Room #6: Molecular Evaluation Dx and Px (Lori Wirth, Bryan McIver)
  2:15 – 3:45 PM We Come Together: Individualized Case Studies Global Review What are the 5 case based pearls? *Presented by 1 attendee & faculty from each room*
  Thyroid Cancer low risk
  Primary HPT
  Thyroid Nodules
  Thyroid Cancer high risk
  2nd HPT
  Molecular evaluation Dx and Px
  Mike Tuttle, Lisa Orloff, Antonia Stephens, Quan Duh, Peter Kopp, Megan Haymart, Bryan Haugen, Peter Angelos, Lori Wirth, Bryan McIver, Carrie Cunningham, Greg Randolph
  3:45 – 4:00 PM Closing Remarks/Adjourn Greg Randolph & Carrie Cunningha